KIMS Healthcare (NSE:KIMS) Doubles Anantapur Hospital Capacity to 500 Beds, Adds Oncology Block
NiveshIQ
Krishna Institute of Medical Sciences Ltd.
NiveshIQ has detected 5 active signals on KIMS. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeAbout Krishna Institute of Medical Sciences Ltd.
Krishna Institute of Medical Sciences Limited (KIMS) operates a network of multi‑specialty hospitals under the KIMS brand, offering comprehensive services ranging from cardiology and orthopaedics to oncology and tele‑medicine. The company’s revenue for the latest fiscal year stood at ₹4,213 crore, with net income of ₹204 crore, reflecting a 35.3% YoY revenue growth driven by expansion into new regions and increased patient volumes. KIMS has recently announced further hospital expansion plans, targeting additional beds and specialty units across key Indian metros. Competitive positioning is strengthened by a diversified service portfolio and strategic partnerships, such as the collaboration with Lal PathLabs, which reported an EBITDA margin of 31% and contributed to KIMS’s revenue lift. The
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹2,498 Cr +13.67% | ₹3,035 Cr +21.49% | ₹3,905 Cr +28.65% |
| EBITDA Margin | 25.64% | 25.79% | 20.54% |
| Net Profit | ₹310.15 Cr -7.78% | ₹384.50 Cr +23.97% | ₹241.40 Cr -37.22% |
| EPS | ₹38.75 | ₹9.61 | ₹6.03 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Stocks to Watch Today: RIL, Maruti Suzuki, EAAA, NTPC, Affle, KIMS, NCC, Jio Platforms, Coal India,...
KIMS Saveera Hospital Anantapur Expands to 500 Beds
Strategic Outlook
- Q1FY27 results: revenue ₹1, 180 Cr, PAT ₹42 Cr, EPS ₹1.04, EBITDA margin 18.9%. Growth context: revenue YoY +35.3%, PAT YoY -47.2%, revenue QoQ +9.8%, PAT QoQ -2.4%. Street verdict: strong miss, revenue surprise +2.7%, PAT surprise -36.8%.
Management highlights network expansion, capacity ramp‑up, throughput gains, new capacity addition and capex deployment ...
FY26 (last completed FY): revenue ₹3, 905 Cr, PAT ₹241 Cr, EBITDA margin 20.5%, EPS ₹6.03. Year-on-year: revenue YoY +28...
More Healthcare stocks
Everything you unlock with a free account
Frequently Asked Questions
What AI signals does NiveshIQ provide for Krishna Institute of Medical Sciences Ltd.?
NiveshIQ detects active intelligence signals for Krishna Institute of Medical Sciences Ltd. (KIMS) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Krishna Institute of Medical Sciences Ltd.?
Krishna Institute of Medical Sciences Ltd. operates in the Healthcare sector with a market capitalisation of ₹2,868,996.3L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.